Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action

Expert Review of Anti-Infective Therapy · Published 2026-07-20 · DOI 10.1080/14787210.2026.2694632

Authors (16)

Muna Al Maslamani, Bosco Paes, Mohamed Janahi, Eman Al Maslamani, Ahmed Abushahin, Ali Almudeer, Manasik Hassan, Moaaz Abo Zeed, Mai Alqubaisi, Ibrahim Janahi, Peter V. Coyle, Mohammed Alkuwari, Khalid Elawad, Hayat Khogali, Hadi Yassine, Salah Al Awaidy

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Maslamani, M., Paes, B., Janahi, M., et al. (2026). Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action. Expert Review of Anti-Infective Therapy. https://doi.org/10.1080/14787210.2026.2694632

Related articles

• Post-tuberculosis lung disease and pulmonary aspergillosis management: challenges and considerations · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Non-prescription antibiotic dispensing and counseling practices in Iraqi community pharmacies: implications for antimicrobial stewardship and resistance containment · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Current perspectives of bacteriophage therapy for multidrug-resistant wound infections · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• How ready are we to use artificial intelligence in our fight against antimicrobial resistance? An ESGAID and EAAS perspective · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Diagnosis and treatment of congenital toxoplasmosis: an updated overview · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Self-medication with antibiotics and knowledge and attitudes toward rational antibiotic use among women of reproductive age · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Tigecycline use in children with multidrug-resistant infections: a single-center experience · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• Hepatitis B in pregnancy and breastfeeding: current approaches to prophylaxis and treatment · Expert Review of Anti-Infective Therapy · 2026 · Same journal
• An evaluation of sipavibart for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals · Expert Review of Anti-Infective Therapy · 2026 · Same journal